BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30762928)

  • 1. Bioinformatic analysis of Cacybp-associated proteins using human glioma databases.
    Xuan C; Gao Y; Jin M; Xu S; Wang L; Wang Y; Han R; Shi K; Chen X; An Q
    IUBMB Life; 2019 Jul; 71(7):827-834. PubMed ID: 30762928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Hub Genes of Mesio Temporal Lobe Epilepsy and Prognostic Biomarkers of Brain Low-grade Gliomas Based on Bioinformatics Analysis.
    Xu J; Sun M; Wang Y; Xie A; Gao J
    Cell Transplant; 2020; 29():963689720978722. PubMed ID: 33327771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of Ubiquitin Ligase Nrdp1-Associated Proteins in Glioma Database.
    Liu Y; Jin M; Gao Y; Wang Y; Xue S; Wang L; Xuan C
    Cell Biochem Biophys; 2020 Sep; 78(3):301-308. PubMed ID: 32562142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
    Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
    Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Genome-Scale Integrated Analysis to Identify Key Genes and Potential Molecular Mechanisms in Recurrence of Lower-Grade Brain Glioma.
    Deng T; Gong YZ; Wang XK; Liao XW; Huang KT; Zhu GZ; Chen HN; Guo FZ; Mo LG; Li LQ
    Med Sci Monit; 2019 May; 25():3716-3727. PubMed ID: 31104065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CacyBP/SIP inhibits the migration and invasion behaviors of glioblastoma cells through activating Siah1 mediated ubiquitination and degradation of cytoplasmic p27.
    Yan S; Li A; Liu Y
    Cell Biol Int; 2018 Feb; 42(2):216-226. PubMed ID: 29024247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candidate genes and microRNAs for glioma pathogenesis and prognosis based on gene expression profiles.
    Xie C; Xu M; Lu D; Zhang W; Wang L; Wang H; Li J; Ren F; Wang C
    Mol Med Rep; 2018 Sep; 18(3):2715-2723. PubMed ID: 30015885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening critical genes associated with malignant glioma using bioinformatics analysis.
    Xu Y; Wang J; Xu Y; Xiao H; Li J; Wang Z
    Mol Med Rep; 2017 Nov; 16(5):6580-6589. PubMed ID: 28901452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An integrated transcriptomic and computational analysis for biomarker identification in human glioma.
    Xing W; Zeng C
    Tumour Biol; 2016 Jun; 37(6):7185-92. PubMed ID: 26663173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CacyBP/SIP protein reduces p53 stability by enhancing Mdm2 activity in p53 mutant glioma cells.
    Qian F; Tang T; Wang S; Wang B; Wang L; Shi H
    Neoplasma; 2021 Jan; 68(1):119-125. PubMed ID: 32880469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The promising novel biomarkers and candidate small molecule drugs in lower-grade glioma: Evidence from bioinformatics analysis of high-throughput data.
    Zhang B; Wu Q; Xu R; Hu X; Sun Y; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Wang Z; Zhou YL
    J Cell Biochem; 2019 Sep; 120(9):15106-15118. PubMed ID: 31020692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Markers Identification in Glioma by Gene Expression Profile Analysis.
    Hu G; Wang R; Wei B; Wang L; Yang Q; Kong D; Du C
    J Comput Biol; 2020 Jan; 27(1):81-90. PubMed ID: 31433208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinformatic identification of candidate biomarkers and related transcription factors in nasopharyngeal carcinoma.
    Ye Z; Wang F; Yan F; Wang L; Li B; Liu T; Hu F; Jiang M; Li W; Fu Z
    World J Surg Oncol; 2019 Apr; 17(1):60. PubMed ID: 30935420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Core Biomarkers Associated with Outcome in Glioma: Evidence from Bioinformatics Analysis.
    Geng RX; Li N; Xu Y; Liu JH; Yuan FE; Sun Q; Liu BH; Chen QX
    Dis Markers; 2018; 2018():3215958. PubMed ID: 30405856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatic Profiling Identifies a Glucose-Related Risk Signature for the Malignancy of Glioma and the Survival of Patients.
    Zhao S; Cai J; Li J; Bao G; Li D; Li Y; Zhai X; Jiang C; Fan L
    Mol Neurobiol; 2017 Dec; 54(10):8203-8210. PubMed ID: 27900679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cysteine-rich 61-associated gene expression profile alterations in human glioma cells.
    Wang R; Wei B; Wei J; Tian Y; Du C
    Mol Med Rep; 2017 Oct; 16(4):5561-5567. PubMed ID: 28849002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CacyBP/SIP protein is important for the proliferation of human glioma cells.
    Shi H; Gao Y; Tang Y; Wu Y; Gong H; Du J; Zheng B; Hu J; Shi Q; Yu R
    IUBMB Life; 2014 Apr; 66(4):286-91. PubMed ID: 24740456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.